{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T17:29:41Z","timestamp":1783186181832,"version":"3.54.6"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010425","name":"Tri-Service General Hospital","doi-asserted-by":"publisher","award":["TSGH-E-114289"],"award-info":[{"award-number":["TSGH-E-114289"]}],"id":[{"id":"10.13039\/501100010425","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019000","name":"Ministry of National Defense Medical Affairs Bureau","doi-asserted-by":"publisher","award":["MND-MAB-C01\\u2013114001"],"award-info":[{"award-number":["MND-MAB-C01\\u2013114001"]}],"id":[{"id":"10.13039\/501100019000","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019000","name":"Ministry of National Defense Medical Affairs Bureau","doi-asserted-by":"publisher","award":["MND-MAB-D-113145"],"award-info":[{"award-number":["MND-MAB-D-113145"]}],"id":[{"id":"10.13039\/501100019000","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019000","name":"Ministry of National Defense Medical Affairs Bureau","doi-asserted-by":"publisher","award":["MND-MAB-C13\\u2013114054"],"award-info":[{"award-number":["MND-MAB-C13\\u2013114054"]}],"id":[{"id":"10.13039\/501100019000","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003559","name":"Ministry of National Defense","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003559","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100022871","name":"National Defense Medical Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100022871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC 112\\u20132314-B-016\\u2013004-MY2"],"award-info":[{"award-number":["NSTC 112\\u20132314-B-016\\u2013004-MY2"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC111\\u20132314-B-016\\u2013022"],"award-info":[{"award-number":["NSTC111\\u20132314-B-016\\u2013022"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC 113\\u20132314-B-016\\u2013044-MY3"],"award-info":[{"award-number":["NSTC 113\\u20132314-B-016\\u2013044-MY3"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.biopha.2025.118526","type":"journal-article","created":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T14:54:02Z","timestamp":1757084042000},"page":"118526","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Targeting KCNN4 channels modulates microglial activation and apoptosis in a PD-relevant inflammatory model"],"prefix":"10.1016","volume":"191","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6455-3032","authenticated-orcid":false,"given":"Hao-Yuan","family":"Hung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I-Hsun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yung-Ni","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting-Yin","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke-Xin","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tin-An","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun\u2011Ting","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7409-608X","authenticated-orcid":false,"given":"Teng-Hui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Chieh","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7884-1246","authenticated-orcid":false,"given":"Jui-Hu","family":"Shih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10423","key":"10.1016\/j.biopha.2025.118526_bib1","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0140-6736(23)01478-2","article-title":"The pathogenesis of parkinson's disease","volume":"403","author":"Morris","year":"2024","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.biopha.2025.118526_bib2","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41577-022-00684-6","article-title":"Inflammation and immune dysfunction in parkinson disease","volume":"22","author":"Tansey","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.biopha.2025.118526_bib3","doi-asserted-by":"crossref","first-page":"488","DOI":"10.3389\/fncel.2018.00488","article-title":"Microglia in neurological diseases: a road map to Brain-Disease Dependent-Inflammatory response","volume":"12","author":"Bachiller","year":"2018","journal-title":"Front Cell Neurosci."},{"issue":"1","key":"10.1016\/j.biopha.2025.118526_bib4","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1186\/s12974-021-02309-6","article-title":"The semantics of microglia activation: neuroinflammation, homeostasis, and stress","volume":"18","author":"Woodburn","year":"2021","journal-title":"J. Neuroinflamm."},{"issue":"7","key":"10.1016\/j.biopha.2025.118526_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/cells12071012","article-title":"Microglia mediated neuroinflammation in parkinson's disease","volume":"12","author":"Isik","year":"2023","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.biopha.2025.118526_bib6","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/PL00005046","article-title":"Pharmacological properties of Ca2+-activated K+ currents of ramified murine brain macrophages","volume":"356","author":"Eder","year":"1997","journal-title":"Naunyn Schmiede Arch. Pharm."},{"issue":"4","key":"10.1016\/j.biopha.2025.118526_bib7","doi-asserted-by":"crossref","first-page":"C796","DOI":"10.1152\/ajpcell.2001.280.4.C796","article-title":"K+ channels and the microglial respiratory burst","volume":"280","author":"Khanna","year":"2001","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"4","key":"10.1016\/j.biopha.2025.118526_bib8","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/S0306-4522(01)00534-6","article-title":"Lysophospholipids induce membrane hyperpolarization in microglia by activation of IKCa1 Ca(2+)-dependent K(+) channels","volume":"109","author":"Schilling","year":"2002","journal-title":"Neuroscience"},{"issue":"6","key":"10.1016\/j.biopha.2025.118526_bib9","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1111\/j.1460-9568.2004.03265.x","article-title":"Functional importance of Ca2+-activated K+ channels for lysophosphatidic acid-induced microglial migration","volume":"19","author":"Schilling","year":"2004","journal-title":"Eur. J. Neurosci."},{"issue":"1","key":"10.1016\/j.biopha.2025.118526_bib10","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1523\/JNEUROSCI.3593-06.2007","article-title":"The Ca2+-activated K+ channel KCNN4\/KCa3.1 contributes to microglia activation and nitric oxide-dependent neurodegeneration","volume":"27","author":"Kaushal","year":"2007","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.biopha.2025.118526_bib11","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1586\/ecp.10.11","article-title":"Therapeutic potential of KCa3.1 blockers: recent advances and promising trends","volume":"3","author":"Wulff","year":"2010","journal-title":"Expert Rev. Clin. Pharm."},{"issue":"9","key":"10.1016\/j.biopha.2025.118526_bib12","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1161\/01.CIR.0000086464.04719.DD","article-title":"Blockade of the intermediate-conductance calcium-activated potassium channel as a new therapeutic strategy for restenosis","volume":"108","author":"Kohler","year":"2003","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.biopha.2025.118526_bib13","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1007\/s12640-017-9842-6","article-title":"Lipopolysaccharide-Induced microglia activation promotes the survival of midbrain dopaminergic neurons in vitro","volume":"33","author":"Zhou","year":"2018","journal-title":"Neurotox. Res"},{"issue":"1","key":"10.1016\/j.biopha.2025.118526_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2006.02.032","article-title":"Microglia induce neural cell death via a proximity-dependent mechanism involving nitric oxide","volume":"1084","author":"Gibbons","year":"2006","journal-title":"Brain Res."},{"issue":"8","key":"10.1016\/j.biopha.2025.118526_bib15","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1002\/jnr.22012","article-title":"Intrastriatal lipopolysaccharide injection induces parkinsonism in C57\/B6 mice","volume":"87","author":"Hunter","year":"2009","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.biopha.2025.118526_bib16","doi-asserted-by":"crossref","DOI":"10.1177\/11795735241312661","article-title":"Neuroprotective potential of isofraxidin: alleviating parkinsonian symptoms, inflammation and microglial activation","volume":"17","author":"Wang","year":"2025","journal-title":"J. Cent. Nerv. Syst. Dis."},{"issue":"3","key":"10.1016\/j.biopha.2025.118526_bib17","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1177\/2472555220950661","article-title":"Development of a Cell-Based assay for identifying K(Ca)3.1 inhibitors using intestinal epithelial cell lines","volume":"26","author":"Jakakul","year":"2021","journal-title":"SLAS Discov."},{"issue":"6","key":"10.1016\/j.biopha.2025.118526_bib18","doi-asserted-by":"crossref","DOI":"10.3390\/membranes13060583","article-title":"Role of Calcium-Activated potassium channels in proliferation, migration and invasion of human chronic myeloid leukemia K562 cells","volume":"13","author":"Vasileva","year":"2023","journal-title":"Membranes"},{"issue":"3","key":"10.1016\/j.biopha.2025.118526_bib19","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1111\/j.1476-5381.2009.00557.x","article-title":"The intermediate conductance Ca2+-activated K+ channel inhibitor TRAM-34 stimulates proliferation of breast cancer cells via activation of oestrogen receptors","volume":"159","author":"Roy","year":"2010","journal-title":"Br. J. Pharm."},{"issue":"1","key":"10.1016\/j.biopha.2025.118526_bib20","doi-asserted-by":"crossref","DOI":"10.1093\/glycob\/cwad087","article-title":"GM1 ganglioside protects against LPS-induced neuroinflammatory and oxidative responses by inhibiting the activation of akt, TAK1 and NADPH oxidase in MG6 microglial cells","volume":"34","author":"Yeh","year":"2024","journal-title":"Glycobiology"},{"issue":"1","key":"10.1016\/j.biopha.2025.118526_bib21","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12993-025-00289-8","article-title":"C18:0 GM3 ganglioside's efficacy in LPS-induced parkinsonism: neuroprotection, inflammatory inhibition and gliosis mitigation","volume":"21","author":"Liu","year":"2025","journal-title":"Behav. Brain Funct."},{"issue":"5","key":"10.1016\/j.biopha.2025.118526_bib22","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/glia.20467","article-title":"Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration","volume":"55","author":"Qin","year":"2007","journal-title":"Glia"},{"key":"10.1016\/j.biopha.2025.118526_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.742065","article-title":"Microglia in neuroinflammation and neurodegeneration: from understanding to therapy","volume":"15","author":"Muzio","year":"2021","journal-title":"Front Neurosci."},{"key":"10.1016\/j.biopha.2025.118526_bib24","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3389\/fncel.2014.00183","article-title":"IL-4 type 1 receptor signaling up-regulates KCNN4 expression, and increases the KCa3. 1 current and its contribution to migration of alternative-activated microglia","volume":"8","author":"Ferreira","year":"2014","journal-title":"Front. Cell. Neurosci."},{"issue":"45","key":"10.1016\/j.biopha.2025.118526_bib25","doi-asserted-by":"crossref","first-page":"16298","DOI":"10.1523\/JNEUROSCI.0047-11.2011","article-title":"Inhibition of the Ca(2)(+)-dependent K(+) channel, KCNN4\/KCa3.1, improves tissue protection and locomotor recovery after spinal cord injury","volume":"31","author":"Bouhy","year":"2011","journal-title":"J. Neurosci."},{"issue":"12","key":"10.1016\/j.biopha.2025.118526_bib26","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1038\/jcbfm.2011.101","article-title":"The KCa3.1 blocker TRAM-34 reduces infarction and neurological deficit in a rat model of ischemia\/reperfusion stroke","volume":"31","author":"Chen","year":"2011","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"10.1016\/j.biopha.2025.118526_bib27","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.brainres.2007.10.027","article-title":"Ion channel expression in resting and activated microglia of hippocampal slices from juvenile mice","volume":"1186","author":"Schilling","year":"2007","journal-title":"Brain Res"},{"key":"10.1016\/j.biopha.2025.118526_bib28","doi-asserted-by":"crossref","first-page":"196","DOI":"10.3389\/fphar.2012.00196","article-title":"Protective roles for potassium SK\/K(Ca)2 channels in microglia and neurons","volume":"3","author":"Dolga","year":"2012","journal-title":"Front Pharm."},{"key":"10.1016\/j.biopha.2025.118526_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtha.2025.05.013","article-title":"KCNN4-mediated potassium ion efflux maintains mitochondrial functions leading to platelet biogenesis","author":"Chen","year":"2025","journal-title":"J. Thromb. Haemost."},{"issue":"5","key":"10.1016\/j.biopha.2025.118526_bib30","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcae345","article-title":"Clinical correlates of dopamine transporter availability in cross-sectional and longitudinal studies with [(18)F]FE-PE2I PET: independent validation with new insights","volume":"6","author":"Honhar","year":"2024","journal-title":"Brain Commun."},{"issue":"1","key":"10.1016\/j.biopha.2025.118526_bib31","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s13550-018-0450-0","article-title":"Dopamine transporter imaging with [(18)F]FE-PE2I PET and [(123)I]FP-CIT SPECT-a clinical comparison","volume":"8","author":"Jakobson Mo","year":"2018","journal-title":"EJNMMI Res"},{"issue":"1","key":"10.1016\/j.biopha.2025.118526_bib32","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13550-023-00974-7","article-title":"[(18)F]FE-PE2I DAT correlates with parkinson's disease duration, stage, and rigidity\/bradykinesia scores: a PET radioligand validation study","volume":"13","author":"Kerstens","year":"2023","journal-title":"EJNMMI Res."},{"issue":"18","key":"10.1016\/j.biopha.2025.118526_bib33","doi-asserted-by":"crossref","first-page":"7699","DOI":"10.1523\/JNEUROSCI.19-18-07699.1999","article-title":"Membrane trafficking regulates the activity of the human dopamine transporter","volume":"19","author":"Melikian","year":"1999","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.biopha.2025.118526_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.105782","article-title":"Cocaine-regulated trafficking of dopamine transporters in cultured neurons revealed by a ph sensitive reporter","volume":"26","author":"Saenz","year":"2023","journal-title":"iScience"},{"issue":"23","key":"10.1016\/j.biopha.2025.118526_bib35","doi-asserted-by":"crossref","first-page":"9414","DOI":"10.1523\/JNEUROSCI.21-23-09414.2001","article-title":"Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence","volume":"21","author":"Volkow","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.biopha.2025.118526_bib36","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.brainres.2010.10.034","article-title":"Activation of tyrosine hydroxylase (TH) gene transcription induced by brain-derived neurotrophic factor (BDNF) and its selective inhibition through Ca(2+) signals evoked via the N-methyl-D-aspartate (NMDA) receptor","volume":"1366","author":"Fukuchi","year":"2010","journal-title":"Brain Res."},{"issue":"2","key":"10.1016\/j.biopha.2025.118526_bib37","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s11481-018-9808-3","article-title":"Low-Dose aspirin upregulates tyrosine hydroxylase and increases dopamine production in dopaminergic neurons: implications for parkinson's disease","volume":"14","author":"Rangasamy","year":"2019","journal-title":"J. Neuroimmune Pharm."},{"issue":"4","key":"10.1016\/j.biopha.2025.118526_bib38","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1124\/mol.64.4.946","article-title":"Tetrahydrobiopterin prevents nitration of tyrosine hydroxylase by peroxynitrite and nitrogen dioxide","volume":"64","author":"Kuhn","year":"2003","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.biopha.2025.118526_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2021.105022","article-title":"Peripheral inflammation induces long-term changes in tyrosine hydroxylase activation in the substantia nigra","volume":"146","author":"Ong","year":"2021","journal-title":"Neurochem. Int"},{"issue":"5","key":"10.1016\/j.biopha.2025.118526_bib40","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24054628","article-title":"LPS triggers acute neuroinflammation and parkinsonism involving NLRP3 inflammasome pathway and mitochondrial CI dysfunction in the rat","volume":"24","author":"Valenzuela-Arzeta","year":"2023","journal-title":"Int J. Mol. Sci."},{"issue":"14","key":"10.1016\/j.biopha.2025.118526_bib41","doi-asserted-by":"crossref","first-page":"3671","DOI":"10.1016\/j.cell.2024.05.030","article-title":"TNF-NF-kappaB-p53 axis restricts in vivo survival of hPSC-derived dopamine neurons","volume":"187","author":"Kim","year":"2024","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.biopha.2025.118526_bib42","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1186\/s12974-022-02612-w","article-title":"Early effects of LPS-induced neuroinflammation on the rat hippocampal glycolytic pathway","volume":"19","author":"Vizuete","year":"2022","journal-title":"J. Neuroinflamm."},{"issue":"3","key":"10.1016\/j.biopha.2025.118526_bib43","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.neuro.2012.02.001","article-title":"Recovery of hypothalamic tuberoinfundibular dopamine neurons from acute toxicant exposure is dependent upon protein synthesis and associated with an increase in parkin and ubiquitin carboxy-terminal hydrolase-L1 expression","volume":"33","author":"Benskey","year":"2012","journal-title":"Neurotoxicology"},{"issue":"9","key":"10.1016\/j.biopha.2025.118526_bib44","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s10337-014-2674-0","article-title":"LC\u2013MS\/MS method for detection of a highly selective KCa3.1 blocker, TRAM-34, in rat plasma","volume":"77","author":"Ye","year":"2014","journal-title":"Chromatographia"},{"issue":"11","key":"10.1016\/j.biopha.2025.118526_bib45","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1592\/phco.26.11.1557","article-title":"Dose-escalation study of ICA-17043 in patients with sickle cell disease","volume":"26","author":"Ataga","year":"2006","journal-title":"Pharmacotherapy"},{"issue":"3","key":"10.1016\/j.biopha.2025.118526_bib46","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1007\/s12975-023-01152-6","article-title":"Repurposing the K(Ca)3.1 blocker senicapoc for ischemic stroke","volume":"15","author":"Lee","year":"2024","journal-title":"Transl. Stroke Res"},{"issue":"14","key":"10.1016\/j.biopha.2025.118526_bib47","doi-asserted-by":"crossref","first-page":"8151","DOI":"10.1073\/pnas.97.14.8151","article-title":"Design of a potent and selective inhibitor of the intermediate-conductance Ca2+-activated K+ channel, IKCa1: a potential immunosuppressant","volume":"97","author":"Wulff","year":"2000","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"9","key":"10.1016\/j.biopha.2025.118526_bib48","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1172\/JCI30836","article-title":"The intermediate-conductance calcium-activated potassium channel KCa3.1 contributes to atherogenesis in mice and humans","volume":"118","author":"Toyama","year":"2008","journal-title":"J. Clin. Invest"},{"issue":"8","key":"10.1016\/j.biopha.2025.118526_bib49","doi-asserted-by":"crossref","first-page":"3991","DOI":"10.1182\/blood-2007-08-110098","article-title":"I.C.A. Investigators, efficacy and safety of the gardos channel blocker, senicapoc (ICA-17043), in patients with sickle cell anemia","volume":"111","author":"Ataga","year":"2008","journal-title":"Blood"},{"issue":"17","key":"10.1016\/j.biopha.2025.118526_bib50","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1161\/CIRCULATIONAHA.108.846634","article-title":"Genetic deficit of SK3 and IK1 channels disrupts the endothelium-derived hyperpolarizing factor vasodilator pathway and causes hypertension","volume":"119","author":"Brahler","year":"2009","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.biopha.2025.118526_bib51","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1161\/01.RES.0000238377.08219.0c","article-title":"Impaired endothelium-derived hyperpolarizing factor-mediated dilations and increased blood pressure in mice deficient of the intermediate-conductance Ca2+-activated K+ channel","volume":"99","author":"Si","year":"2006","journal-title":"Circ. Res"},{"issue":"13","key":"10.1016\/j.biopha.2025.118526_bib52","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.2174\/092986707780831186","article-title":"Modulators of small- and intermediate-conductance calcium-activated potassium channels and their therapeutic indications","volume":"14","author":"Wulff","year":"2007","journal-title":"Curr. Med Chem."},{"issue":"5","key":"10.1016\/j.biopha.2025.118526_bib53","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1172\/JCI118537","article-title":"Therapy with oral clotrimazole induces inhibition of the gardos channel and reduction of erythrocyte dehydration in patients with sickle cell disease","volume":"97","author":"Brugnara","year":"1996","journal-title":"J. Clin. Invest"},{"issue":"1","key":"10.1016\/j.biopha.2025.118526_bib54","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1007\/s11033-024-09935-2","article-title":"Early expression of monomeric and oligomeric alpha-synuclein and reduction of tyrosine hydroxylase following intranigral injection of lipopolysaccharide","volume":"51","author":"Lomeli-Lepe","year":"2024","journal-title":"Mol. Biol. Rep."},{"issue":"1","key":"10.1016\/j.biopha.2025.118526_bib55","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/s41531-024-00640-2","article-title":"Microglial inhibition alleviates alpha-synuclein propagation and neurodegeneration in parkinson's disease mouse model","volume":"10","author":"Thi Lai","year":"2024","journal-title":"NPJ Park. Dis."},{"key":"10.1016\/j.biopha.2025.118526_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.bpc.2021.106736","article-title":"Intermediates of alpha-synuclein aggregation: implications in parkinson's disease pathogenesis","volume":"281","author":"Gadhe","year":"2022","journal-title":"Biophys. Chem."},{"issue":"22","key":"10.1016\/j.biopha.2025.118526_bib57","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21228645","article-title":"The role of alpha-Synuclein oligomers in parkinson's disease","volume":"21","author":"Du","year":"2020","journal-title":"Int. J. Mol. Sci."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225007206?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225007206?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T01:48:18Z","timestamp":1772848098000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332225007206"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":57,"alternative-id":["S0753332225007206"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118526","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting KCNN4 channels modulates microglial activation and apoptosis in a PD-relevant inflammatory model","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118526","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118526"}}